These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15756299)

  • 1. Schistosomal hepatic fibrosis and the interferon gamma receptor: a linkage analysis using single-nucleotide polymorphic markers.
    Blanton RE; Salam EA; Ehsan A; King CH; Goddard KA
    Eur J Hum Genet; 2005 May; 13(5):660-8. PubMed ID: 15756299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene.
    Dessein AJ; Hillaire D; Elwali NE; Marquet S; Mohamed-Ali Q; Mirghani A; Henri S; Abdelhameed AA; Saeed OK; Magzoub MM; Abel L
    Am J Hum Genet; 1999 Sep; 65(3):709-21. PubMed ID: 10441577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni).
    Chevillard C; Moukoko CE; Elwali NE; Bream JH; Kouriba B; Argiro L; Rahoud S; Mergani A; Henri S; Gaudart J; Mohamed-Ali Q; Young HA; Dessein AJ
    J Immunol; 2003 Nov; 171(10):5596-601. PubMed ID: 14607968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection.
    de Jesus AR; Magalhães A; Miranda DG; Miranda RG; Araújo MI; de Jesus AA; Silva A; Santana LB; Pearce E; Carvalho EM
    Infect Immun; 2004 Jun; 72(6):3391-7. PubMed ID: 15155645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to periportal (Symmers) fibrosis in human schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression.
    Mohamed-Ali Q; Elwali NE; Abdelhameed AA; Mergani A; Rahoud S; Elagib KE; Saeed OK; Abel L; Magzoub MM; Dessein AJ
    J Infect Dis; 1999 Oct; 180(4):1298-306. PubMed ID: 10479161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disagreement between ultrasound and magnetic resonance imaging in the identification of schistosomal periportal fibrosis.
    Silva LC; Pereira AC; Queiroz LC; Andrade LM; Antunes CM; Lambertucci JR
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():279-82. PubMed ID: 17308782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonography of periportal fibrosis in schistosomiasis mansoni in Brazil.
    Gerapacher-Lara R; Pinto-Silva RA; Rayes AA; Drummond SC; Lambertucci JR
    Trans R Soc Trop Med Hyg; 1997; 91(3):307-9. PubMed ID: 9231204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reinfections and the development of schistosomal periportal fibrosis in the murine model].
    Santos AB; de Souza MM; Andrade ZA
    Rev Soc Bras Med Trop; 2000; 33(2):197-200. PubMed ID: 10881134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Egyptians, a mutation in the lymphotoxin-alpha gene may increase susceptibility to hepatitis C virus but not that to schistosomal infection.
    Elsammak MY; Al-Sharkaweey RM; Ragab MS; Amin GM; Kandil MH
    Ann Trop Med Parasitol; 2008 Dec; 102(8):709-16. PubMed ID: 19000388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosoma mansoni: magnetic resonance analysis of liver fibrosis according to WHO patterns for ultrasound assessment of schistosomiasis-related morbidity.
    Silva LC; Andrade LM; Queiroz LC; Voieta I; Azeredo LM; Antunes CM; Lambertucci JR
    Mem Inst Oswaldo Cruz; 2010 Jul; 105(4):467-70. PubMed ID: 20721492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic predisposition to bilharziasis in humans: research methods and application to the study of Schistosoma mansoni infection].
    Abel L; Marquet S; Chevillard C; elWali NE; Hillaire D; Dessein A
    J Soc Biol; 2000; 194(1):15-8. PubMed ID: 11107544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and familial aggregation of schistosomal liver morbidity in Kenya: evaluation by new ultrasound criteria.
    Kariuki HC; Mbugua G; Magak P; Bailey JA; Muchiri EM; Thiongo FW; King CH; Butterworth AE; Ouma JH; Blanton RE
    J Infect Dis; 2001 Mar; 183(6):960-6. PubMed ID: 11237814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection.
    Coutinho HM; Acosta LP; Wu HW; McGarvey ST; Su L; Langdon GC; Jiz MA; Jarilla B; Olveda RM; Friedman JF; Kurtis JD
    J Infect Dis; 2007 Jan; 195(2):288-95. PubMed ID: 17191174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis.
    Vennervald BJ; Kenty L; Butterworth AE; Kariuki CH; Kadzo H; Ireri E; Amaganga C; Kimani G; Mwatha J; Otedo A; Booth M; Ouma JH; Dunne DW
    Trop Med Int Health; 2004 Apr; 9(4):461-70. PubMed ID: 15078264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal ultrasound in the evaluation of fibrosis and portal hypertension in an area of schistosomiasis low endemicity.
    Espírito Santo MC; Azeredo LM; Teles HM; Gryschek RC; Ferreira CS; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 2008; 50(2):117-9. PubMed ID: 18488092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.
    Alves Oliveira LF; Moreno EC; Gazzinelli G; Martins-Filho OA; Silveira AM; Gazzinelli A; Malaquias LC; LoVerde P; Leite PM; Correa-Oliveira R
    Infect Immun; 2006 Feb; 74(2):1215-21. PubMed ID: 16428771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni.
    Domingues AL; Medeiros TB; Lopes EP
    Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):802-7. PubMed ID: 22124551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
    Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
    J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection and disease in human schistosomiasis mansoni are under distinct major gene control.
    Dessein AJ; Marquet S; Henri S; El Wali NE; Hillaire D; Rodrigues V; Prata A; Ali QM; Gharib B; de Reggi M; Magzoub MM; Saeed OK; Abdelhameed AA; Abel L
    Microbes Infect; 1999 Jun; 1(7):561-7. PubMed ID: 10603573
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of upper gastrointestinal bleeding in patients with schistosomal periportal fibrosis.
    Eltoum IA; Taha TE; Saad AM; Suliman SM; Bennett JL; Nash TE; Homeida MM
    Br J Surg; 1994 Jul; 81(7):996-9. PubMed ID: 7922096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.